Document Preview Unavailable

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia

Pastoors, Dorien; Havermans, Marije; Mulet-Lazaro, Roger; Smeenk, Leonie; Ottema, Sophie; et al.  bioRxiv, Jan 2, 2025.

You might have access to this document